Metabolic risk factors and leptin DNA methylation dynamics in a sample of Egyptian women with obesity
Abstract
Metabolic health is negatively affected by obesity, causing a cluster of conditions known as metabolic syndrome that increase the risk for cardiovascular disease and type 2diabetes. Scientific research suggests that actions and expression of the Leptin hormone are strongly influenced by epigenetic changes such as methylation of promoter sites, which is linked to metabolic disorders occurring in obesity. The current study aimed to evaluate metabolic risk factors and its association with DNA methylation at the promoter region of the Leptin gene in a sample of Egyptian women with obesity pre and post dietary intervention. This longitudinal intervention study included 58 obese females aged 25–60 years. Participants were prescribed a 3-month weight loss program. Baseline and endpoint anthropometric parameters were measured and blood samples for metabolic assessment were drawn. The methylation of Leptin gene promoters was investigated using PCR as well as measured Leptin levels before and after the intervention program. The sample was classified into two groups: 35 metabolically healthy women with obesity (MHO) and 23 metabolically unhealthy women with obesity (MUO), based on the presence of three or more of the Metabolic Syndrome criteria. Pre-intervention: higher Leptin methylation was generally associated with better metabolic profiles in the MHO group. While post-intervention, the correlation patterns suggest different epigenetic responses between the two groups, with the MHO group maintaining protective associations, and the MUO group showing correlations indicating improved metabolic dysfunction. Current data suggest that Leptin gene methylation patterns serve as biomarkers for metabolic health status and therapeutic targets for intervention response in individuals with obesity.
Related
- Dietary Fructose Intake, Metabolic Profile, and Liver Disease-Related Quality of Life in Adults with Obesity and MASLD: A Cross-Sectional Study
- Antagonistic DNA methylation dynamics at a single locus controls pollen tube guidance in Arabidopsis
- The Crosstalk Between Metabolic Reprogramming and Histone Methylation in Tumor Immunity and Immunotherapy
- Metabolic control of methylation landscapes in cancer growth and plasticity: targeting the epigenetic-metabolic axis with natural compounds and emerging therapies.
- DNA Methylation and Metabolic Syndrome in Midlife Women of the ELEMENT Cohort.
BibTeX
@article{hassan2026metabolic,
title = {{Metabolic risk factors and leptin DNA methylation dynamics in a sample of Egyptian women with obesity}},
author = {Nayera E. Hassan and Sahar A. El-Masry and Ayat N. Kamal and Rehab M. Mosaad and Maha M. Kobesiy and Nayra Sh. Mehanna and Mohamed S. Kishta and Ahmed S. Ismail and Mai M. Badie and Khadija M. Alian and Mahmoud A. S. Afify and Heba T. Aboud},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-72136-3},
url = {https://www.nature.com/articles/s41598-026-72136-3},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Metabolic risk factors and leptin DNA methylation dynamics in a sample of Egyptian women with obesity
AU - Nayera E. Hassan
AU - Sahar A. El-Masry
AU - Ayat N. Kamal
AU - Rehab M. Mosaad
AU - Maha M. Kobesiy
AU - Nayra Sh. Mehanna
AU - Mohamed S. Kishta
AU - Ahmed S. Ismail
AU - Mai M. Badie
AU - Khadija M. Alian
AU - Mahmoud A. S. Afify
AU - Heba T. Aboud
PY - 2026
DA - 2026/10/15
JO - Scientific Reports
DO - 10.1038/s41598-026-72136-3
UR - https://www.nature.com/articles/s41598-026-72136-3
AB - Metabolic health is negatively affected by obesity, causing a cluster of conditions known as metabolic syndrome that increase the risk for cardiovascular disease and type 2diabetes. Scientific research suggests that actions and expression of the Leptin hormone are strongly influenced by epigenetic changes such as methylation of promoter sites, which is linked to metabolic disorders occurring in obesity. The current study aimed to evaluate metabolic risk factors and its association with DNA methylation at the promoter region of the Leptin gene in a sample of Egyptian women with obesity pre and post dietary intervention. This longitudinal intervention study included 58 obese females aged 25–60 years. Participants were prescribed a 3-month weight loss program. Baseline and endpoint anthropometric parameters were measured and blood samples for metabolic assessment were drawn. The methylation of Leptin gene promoters was investigated using PCR as well as measured Leptin levels before and after the intervention program. The sample was classified into two groups: 35 metabolically healthy women with obesity (MHO) and 23 metabolically unhealthy women with obesity (MUO), based on the presence of three or more of the Metabolic Syndrome criteria. Pre-intervention: higher Leptin methylation was generally associated with better metabolic profiles in the MHO group. While post-intervention, the correlation patterns suggest different epigenetic responses between the two groups, with the MHO group maintaining protective associations, and the MUO group showing correlations indicating improved metabolic dysfunction. Current data suggest that Leptin gene methylation patterns serve as biomarkers for metabolic health status and therapeutic targets for intervention response in individuals with obesity.
SN - 2045-2322
ER -